Does authors’ biodata in clinical trials registry affect blind peer review process? For the consideration of medical journal editors
Abstract
The clinical trial registry is an important platform to register clinical trials to be conducted, along with all the related information of the study, the institutions involved and the details about the authors. In the author’s opinion, this disclosure of information can effect the blind peer review process. Although medical journal editors try best to evaluate all related information, relationships and conflicts, but the disclosure in trials registry can effect the double-blind review process. This can also effect the reviewer’s decsion and can be a source of bias. The authors of medical journals should consider this to further keep the review process transparent and unbiased.
Key words: Trials registry; Clinical trial; Medical journal; Review; Bias
Citation: Mahmood T. Does authors’ biodata in clinical trials registry affect blind peer review process? For the consideration of medical journal editors. Anaesth. pain intensive care 2022;26(3):280-282.
Received: April 05, 2022, Accepted: May 12, 2022
